Corbus Pharmaceuticals, Inc.
100 River Ridge Drive
Norwood
Massachusetts
02062
United States
Tel: 617-963-0100
Fax: 617-663-6085
Website: http://www.corbuspharma.com/
124 articles about Corbus Pharmaceuticals, Inc.
-
Corbus Announces $27.2 Million Registered Direct Offering
2/28/2017
-
Corbus Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation In Alveolar Macrophages From Cystic Fibrosis Patients
2/24/2017
-
Why Corbus' Stock Rocketed 412% Upwards in 2016
1/17/2017
-
Corbus Release: Pharma Receives Orphan Designation For JBT-101 For The Treatment Of Systemic Sclerosis In The European Union
1/17/2017
-
Why Massachusetts’ Corbus Keeps a ‘Remarkably Young Staff’—And How it Plans to Double Headcount
12/9/2016
-
Corbus To Ring The Nasdaq Stock Market Closing Bell
12/6/2016
-
Little Corbus Gains Close to $180 Million in Market Cap on Mid-Stage Systemic Sclerosis Data
11/14/2016
-
Unnamed Fund Manager With Reliable Track Record Says High-Flying Corbus is About to Crash
10/25/2016
-
Corbus Reports 2016 Second Quarter Financial Results And Provides Business Update
8/15/2016
-
Corbus Completes $15 Million Registered Direct Offering
6/15/2016
-
Corbus Announces $15 Million Registered Direct Offering
6/10/2016
-
Corbus Release: Non-Deal Road Show Adds Confidence To Our Bullish Thesis
6/2/2016
-
Corbus Expands Clinical Development Of Resunab With Phase 2 Trial For The Treatment Of Systemic Lupus Erythematosus
3/8/2016
-
Corbus To Present At Biotech Showcase On January 12, 2016
1/5/2016
-
Corbus To Present At Two Upcoming Investor Conferences In December 2015
11/24/2015
-
Corbus Reports 2015 Third Quarter Financial Results
11/13/2015
-
Corbus Announces FDA Orphan Drug Designation And Fast Track Status Of ResunabFor The Treatment Of Cystic Fibrosis
10/20/2015
-
Corbus Announces First Patient Dosed In Phase 2 Study Of Resunab For Treatment Of Cystic Fibrosis
10/15/2015
-
Corbus To Present At The 14th Annual BIO Investor Forum
10/14/2015
-
Corbus Announces First Patient Dosed In Phase 2 Study Of Resunab For Systemic Sclerosis
10/7/2015